Title
Behavioural strategies to reduce HIV transmission: how to make them work better
Date Issued
01 January 2008
Access level
open access
Resource Type
review
Author(s)
Publisher(s)
Elsevier B.V.
Abstract
This paper makes five key points. First is that the aggregate effect of radical and sustained behavioural changes in a sufficient number of individuals potentially at risk is needed for successful reductions in HIV transmission. Second, combination prevention is essential since HIV prevention is neither simple nor simplistic. Reductions in HIV transmission need widespread and sustained efforts, and a mix of communication channels to disseminate messages to motivate people to engage in a range of options to reduce risk. Third, prevention programmes can do better. The effect of behavioural strategies could be increased by aiming for many goals (eg, delay in onset of first intercourse, reduction in number of sexual partners, increases in condom use, etc) that are achieved by use of multilevel approaches (eg, couples, families, social and sexual networks, institutions, and entire communities) with populations both uninfected and infected with HIV. Fourth, prevention science can do better. Interventions derived from behavioural science have a role in overall HIV-prevention efforts, but they are insufficient when used by themselves to produce substantial and lasting reductions in HIV transmission between individuals or in entire communities. Fifth, we need to get the simple things right. The fundamentals of HIV prevention need to be agreed upon, funded, implemented, measured, and achieved. That, presently, is not the case. © 2008 Elsevier Ltd. All rights reserved.
Start page
669
End page
684
Volume
372
Issue
9639
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-49649116323
PubMed ID
Source
The Lancet
ISSN of the container
01406736
Sponsor(s)
Support for this work was provided primarily by The Ford Foundation; The UCLA Center for HIV Identification, Treatment, and Prevention Services (CHIPTS; Mary Jane Rotheram-Borus, Director, funded by the National Institute of Mental Health grant number 2P30MH058107); The Diana, Princess of Wales Memorial Fund; The Franklin Mint Foundation; The MAC AIDS Fund; and The UCLA AIDS Institute and the UCLA Center for AIDS Research (Jerome Zack, Principal Investigator, funded by The National Institute of Allergy and Infectious Diseases, grant number AI28697). Other supporters included: The John M Lloyd Foundation, and the Columbia Center for HIV Clinical and Behavioral Studies (Anke Ehrhrardt, Director, funded by the National Institute of Mental Health grant number P30MH43520). Support was also provided by the HIV Prevention Trials Network (HPTN) and sponsored by the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the National Institutes of Health, US Department of Health and Human Services, through cooperative agreement U01-AI-46749 with Family Health International, U01-AI-46702 with Fred Hutchinson Cancer Research Center, U01-AI-47984 with Johns Hopkins University, and U01-AI-48014 with the University of Pennsylvania. The sponsors had no role in the preparation of this paper and none of the views expressed herein represent those of the sponsors or any employees of the sponsors. We thank Judith Auerbach and Peter Aggleton for the extensive comments on earlier drafts of this paper; Purnima Mane of UNFPA for her guidance and feedback as this paper evolved; our colleagues at UNAIDS who contributed vital data and thoughtful comments on earlier drafts of this paper including Michael Bartos, Paul De Lay, Barbara de Zalduondo, Catherine Hankins, and Matthew Warner-Smith; and Professor King Holmes for coining the term “highly active HIV prevention” in figure 1 .
Sources of information:
Directorio de Producción Científica
Scopus